Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
2006.
Current awareness: Pharmacoepidemiology and drug safety.
Pharmacoepidemiology and Drug Safety,
Vol. 15,
Issue. 7,
Saddichha, S.
Manjunatha, N.
Ameen, S.
and
Akhtar, S.
2008.
Diabetes and schizophrenia – effect of disease or drug? Results from a randomized, double‐blind, controlled prospective study in first‐episode schizophrenia.
Acta Psychiatrica Scandinavica,
Vol. 117,
Issue. 5,
p.
342.
Dickerson, Faith
Rubalcaba, Elizabeth
Viscidi, Raphael
Yang, Shuojia
Stallings, Cassie
Sullens, Anne
Origoni, Andrea
Leister, Flora
and
Yolken, Robert
2008.
Polymorphisms in human endogenous retrovirus K-18 and risk of type 2 diabetes in individuals with schizophrenia.
Schizophrenia Research,
Vol. 104,
Issue. 1-3,
p.
121.
Nasrallah, H A
2008.
Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles.
Molecular Psychiatry,
Vol. 13,
Issue. 1,
p.
27.
Nguyen, Dang
Brakoulias, Vlasios
and
Boyce, Philip
2009.
An Evaluation of Monitoring Practices in Patients on Second Generation Antipsychotics.
Australasian Psychiatry,
Vol. 17,
Issue. 4,
p.
295.
Rezaei, Omid
Khodaie-Ardakani, Mohammad-Reza
Mandegar, Mohammad Hossein
Dogmehchi, Ensyeh
and
Goodarzynejad, Hamidreza
2009.
Prevalence of Metabolic Syndrome among an Iranian Cohort of Inpatients with Schizophrenia.
The International Journal of Psychiatry in Medicine,
Vol. 39,
Issue. 4,
p.
451.
Chien, I-Chia
Hsu, Jer-Hwa
Lin, Ching-Heng
Bih, Shin-Huey
Chou, Yiing-Jenq
and
Chou, Pesus
2009.
Prevalence of diabetes in patients with schizophrenia in Taiwan: A population-based National Health Insurance study.
Schizophrenia Research,
Vol. 111,
Issue. 1-3,
p.
17.
Lin, P.I.
and
Shuldiner, A.R.
2010.
Rethinking the genetic basis for comorbidity of schizophrenia and type 2 diabetes.
Schizophrenia Research,
Vol. 123,
Issue. 2-3,
p.
234.
Murakami, Hiroshi
Tamasawa, Naoki
Yamashita, Maki
Takayasu, Shinobu
Nigawara, Takeshi
Matsui, Jun
and
Suda, Toshihiro
2010.
Altered pain perception in schizophrenia.
The Lancet,
Vol. 375,
Issue. 9717,
p.
864.
Okumura, Yasuyuki
Ito, Hiroto
Kobayashi, Mika
Mayahara, Ken
Matsumoto, Yoshio
and
Hirakawa, Junichi
2010.
Prevalence of diabetes and antipsychotic prescription patterns in patients with schizophrenia: A nationwide retrospective cohort study.
Schizophrenia Research,
Vol. 119,
Issue. 1-3,
p.
145.
Ress, Claudia
Tschoner, Alexander
Kaser, Susanne
and
Ebenbichler, Christoph F.
2011.
Psychopharmaka und Diabetes.
Wiener Medizinische Wochenschrift,
Vol. 161,
Issue. 21-22,
p.
531.
Gonzalez, Jeffrey S.
Esbitt, Sabrina A.
Schneider, Havah E.
Osborne, Patricia J.
and
Kupperman, Elyse G.
2011.
Psychological Co-morbidities of Physical Illness.
p.
73.
Hsu, Jer-Hwa
Chien, I-Chia
Lin, Ching-Heng
Chou, Yiing-Jenq
and
Chou, Pesus
2011.
Incidence of Diabetes in Patients with Schizophrenia: A Population-Based Study.
The Canadian Journal of Psychiatry,
Vol. 56,
Issue. 1,
p.
19.
Chen, Da Chun
Zhou, Ming Ai
Zhou, Dong Hao
Xiu, Mei Hong
Wu, Gui Ying
Kosten, Thomas R.
and
Zhang, Xiang Yang
2011.
Gender differences in the prevalence of diabetes mellitus in chronic hospitalized patients with schizophrenia on long-term antipsychotics.
Psychiatry Research,
Vol. 186,
Issue. 2-3,
p.
451.
Zhang, Xuan
Guan, Song‐Lei
Wang, Zhen‐Qi
You, Yang
Sun, Shi‐Long
Hui, Li
Miao, Li‐ning
Yu, Yaqin
Kosten, Thomas R
and
Zhang, Xiang Yang
2012.
No association between the type 2 diabetes mellitus susceptibility gene, SLC30A8 and schizophrenia in a Chinese population.
Human Psychopharmacology: Clinical and Experimental,
Vol. 27,
Issue. 4,
p.
392.
Lindenmayer, J.
Tedeschi, Frank
Yusim, Anna
Khan, Anzalee
Kaushik, Saurabh
Smith, Robert
and
Parakadavil, Mohan
2012.
Ziprasidone's Effect on Metabolic Markers in Patients with Diabetes and Chronic Schizophrenia.
Clinical Schizophrenia & Related Psychoses,
Vol. 5,
Issue. 4,
p.
185.
Han, Mei
Huang, Xu-Feng
Chen, Da Chun
Xiu, Meihong
Kosten, Thomas R.
Zhang, Xiang Yang
and
Hashimoto, Kenji
2013.
Diabetes and Cognitive Deficits in Chronic Schizophrenia: A Case-Control Study.
PLoS ONE,
Vol. 8,
Issue. 6,
p.
e66299.
Foley, Debra L.
Mackinnon, Andrew
Watts, Gerald F.
Shaw, Jonathan E.
Magliano, Dianna J.
Castle, David J.
McGrath, John J.
Waterreus, Anna
Morgan, Vera A.
Galletly, Cherrie A.
and
Vinciguerra, Manlio
2013.
Cardiometabolic Risk Indicators That Distinguish Adults with Psychosis from the General Population, by Age and Gender.
PLoS ONE,
Vol. 8,
Issue. 12,
p.
e82606.
Foley, Debra L.
Mackinnon, Andrew
Morgan, Vera A.
Watts, Gerald F.
McGrath, John J.
Castle, David J.
Waterreus, Anna
and
Galletly, Cherrie A.
2014.
Predictors of type 2 diabetes in a nationally representative sample of adults with psychosis.
World Psychiatry,
Vol. 13,
Issue. 2,
p.
176.
van Beveren, N J M
Schwarz, E
Noll, R
Guest, P C
Meijer, C
de Haan, L
and
Bahn, S
2014.
Evidence for disturbed insulin and growth hormone signaling as potential risk factors in the development of schizophrenia.
Translational Psychiatry,
Vol. 4,
Issue. 8,
p.
e430.
Comments
No Comments have been published for this article.